I LOVE LIFE THERAPIES LIMITED

Executive Summary

I Love Life Therapies Limited, incorporated in 2023, shows early-stage financial instability with negative net assets and reliance on director loans for liquidity. While compliant with filing obligations and supported by director funding, the company currently faces high solvency and liquidity risks. Further due diligence is essential to evaluate operational viability and the sustainability of financial support.

I LOVE LIFE THERAPIES LIMITED - Analysis Report

Company Number: 14780940

Analysis Date: 2025-07-29 18:59 UTC

1. Risk Rating: HIGH
   The company exhibits significant solvency and liquidity concerns, reflected by negative net assets and net current assets shortly after incorporation. The minimal cash balance and reliance on director loans to fund operations further heighten financial risk.

2. Key Concerns:

• Negative net assets of £1,184 and net current liabilities indicate the company is insolvent on a balance sheet basis.
• Extremely low cash on hand (£41) suggests very limited liquidity to meet short-term obligations.
• Dependence on director loans (£1,225) to finance operations raises concerns about sustainability if director support ceases.

3. Positive Indicators:

• The company is current with all statutory filings (accounts and confirmation statement) with no overdue reports, indicating compliance and good governance practices.
• Directors have disclosed ongoing support via a loan and affirm going concern, implying some level of financial backing.
• The business operates in the physical well-being and human health sector, which can offer growth opportunities if managed effectively.

4. Due Diligence Notes:

• Investigate the terms and security of director loans, including repayment expectations and the likelihood of continued funding.
• Assess the company’s operational plan to generate positive cash flow and profitability, including customer pipeline and income projections.
• Review detailed management accounts and cash flow forecasts since incorporation to evaluate current trading performance and operational sustainability.
• Confirm no undisclosed contingent liabilities or off-balance-sheet commitments exist that could exacerbate financial distress.
• Verify the directors’ experience and capacity to manage turnaround or growth in this sector.